GRN and COVID-19: Therefore, considering the similarity of the immunopathogenesis of heart failure following COVID-19 with other cases reviewed in this article, PGRN, as a regulator of inflammatory responses affecting the critical immunological events involved in the occurrence of damage caused by inflammation, can be proposed as a therapeutic and diagnostic target in the type of CVDs caused by COVID-19.